Sacubitril/valsartan versus valsartan in regressing myocardial fibrosis in hypertension: a prospective, randomized, open-label, blinded endpoint clinical trial protocol

  1. Lee, V.
  2. Zheng, Q.
  3. Toh, D.-F.
  4. Pua, C.J.
  5. Bryant, J.A.
  6. Lee, C.-H.
  7. Cook, S.A.
  8. Butler, J.
  9. Díez, J.
  10. Richards, A.M.
  11. Le, T.-T.
  12. Chin, C.W.L.
Journal:
Frontiers in Cardiovascular Medicine

ISSN: 2297-055X

Year of publication: 2023

Volume: 10

Type: Article

DOI: 10.3389/FCVM.2023.1248468 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus